Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab. (1st December 2022) - van der Schoot, Lara S.; Atalay, Selma; Otero, Marisol E.; Kievit, Wietske; van den Reek, Juul M.P.A.; de Jong, Elke M.G.J.